Siponimod Patent Expiration

Siponimod is Used for treating multiple sclerosis. It was first introduced by Novartis Pharmaceuticals Corp in its drug Mayzent on Mar 26, 2019. 2 different companies have introduced drugs containing Siponimod.


Siponimod Patents

Given below is the list of patents protecting Siponimod, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Mayzent US11944602 Treatment of autoimmune disease in a patient receiving additionally a beta-blocker Jul 24, 2036 Novartis
Mayzent US12071402 Immunosuppressant formulations Jan 05, 2032 Novartis
Mayzent US8492441 Dosage regimen of an S1P receptor agonist Nov 30, 2030 Novartis
Mayzent US7939519 Immunosuppresant compounds and compositions Aug 27, 2028 Novartis



Siponimod's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Siponimod Generic API Manufacturers

Several generic applications have been filed for Siponimod.

Given below is the list of companies who have filed for Siponimod generic, along with the locations of their manufacturing plants worldwide.


1. RICONPHARMA LLC

Riconpharma Llc has filed for 3 different strengths of generic version for Siponimod. Given below are the details of the strengths of this generic introduced by Riconpharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.25MG BASE

tablet Prescription ORAL AB Apr 22, 2025
EQ 1MG BASE

tablet Prescription ORAL AB Apr 22, 2025
EQ 2MG BASE

tablet Prescription ORAL AB Apr 22, 2025


Manufacturing Plant Locations
New

Riconpharma Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Riconpharma Llc as present at those locations.

Country City Firm Name
United States
Denville RiconPharma LLC